Targeting Acetyl-CoA Carboxylase Suppresses <i>De Novo</i> Lipogenesis and Tumor Cell Growth in Multiple Myeloma

ACC1 is a metabolic vulnerability in MYC-driven multiple myeloma. Inhibiting ACC1 disrupts lipid homeostasis, induces ER stress, and causes oxidative damage, impairing cell survival. Targeting lipid synthesis pathways, especially in MYC-dependent subtypes, offers a promising therapeutic strategy for multiple myeloma.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-03-07
DOI
https://doi.org/10.1158/1078-0432.ccr-24-2000
Citations
9
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
7.25
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma

Domenico Maisano, Caroline F. Ribeiro, Fabio Socciarelli, Giorgio Inghirami et al.
9 citations
Clinical Cancer Research
Histone Deacetylase Inhibitors Research
7.25
article

Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma

Domenico Maisano, Caroline F. Ribeiro, Fabio Socciarelli, Giorgio Inghirami, Silvia Rodrigues, Eugenio Morelli, Alessandra Romano, Katia Todoerti, Marcello Turi, Kenneth Carl Anderson, Mehmet Samur, Nikhil C. Munshi, Mariateresa Fulciniti, Johany Peñailillo, Anıl Aktaş Samur, Na Liu, Cesarina Giallongo, Massimo F. Loda, Vanessa Favasuli, Annamaria Gullà, Francesca Barello, Nicola Amodio, Claire Gao, Yao Yao, Chandraditya Chakraborty
article en
9 citations

Abstract

ACC1 is a metabolic vulnerability in MYC-driven multiple myeloma. Inhibiting ACC1 disrupts lipid homeostasis, induces ER stress, and causes oxidative damage, impairing cell survival. Targeting lipid synthesis pathways, especially in MYC-dependent subtypes, offers a promising therapeutic strategy for multiple myeloma.

Clinical Cancer ResearchVol. 31(10)
Brigham and Women's Hospital (US), Xuzhou Medical College (CN), Cornell University (US), VA Boston Healthcare System (US), Magna Graecia University (IT), University of Catania (IT), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US), Lincoln College (US), Candiolo Cancer Institute (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Weill Cornell Medicine (US)
Responsible consumption and production
Openalex Percentile: Top 3%
Histone Deacetylase Inhibitors Research
7.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.